Human appetite control by glucagon-like peptide receptor binding compounds

• US 20060128627A1
• Filed: 02/06/2006
• Published: 06/15/2006
• Est. Priority Date: 03/19/1998
• Status: Abandoned Application

• Current Assignee: Amylin Pharmaceuticals Incorporated (Bristol-Myers Squibb Company)
• Original Assignee: Amylin Pharmaceuticals Incorporated (Bristol-Myers Squibb Company)
• Inventors: Coolidge, Thomas R., Beglinger, Christoph, Goke, Burkhard
• Application Number:
  US11/348,148
• Publication Number:
  US 20060128627A1
• Time in Patent Office: Days
• US Class Current: 514/4.900
• CPC Class Codes: A61K 38/26 Glucagons

Abstract

A composition including a compound which binds to a receptor for glucagon-like peptide-1 and a pharmaceutical carrier. The amount of the compound present is effective to control appetite in a human. Also disclosed is a method for controlling appetite and for reducing food intake in a human by administering to the human a composition comprising a compound which binds to a receptor for glucagon-like peptide-1 and a pharmaceutical carrier.

Claims

1. A method for controlling appetite in a human by administering to the human a composition comprising:

a compound which binds to a receptor for glucagon-like peptide-1 and a pharmaceutical carrier, said composition containing an amount of said compound effective to control appetite in a human.

2. A method for reducing spontaneous food intake in a human by administering to the human a composition comprising:

a compound which binds to the receptor for glucagon-like peptide-1 and a pharmaceutical carrier, said composition containing an amount of said compound effective to reduce spontaneous food intake in a human.